News
Dr Cañete gives a masterclass in Vietnam on radiofrequency treatment for uterine fibroids
Dr Cañete, from the Quirónsalud Toledo Hospital, gives a masterclass in Vietnam on radiofrequency treatment for uterine fibroids A select group of fifty Vietnamese gynaecologists attended the masterclass held in the Tu Du Hospital in Ho Chi Minh City....
Presentation of the iVascular clinical results – LINC 2019
Cardiva launches the new Navitian coronary microcatheter
Cardiva collaborates with the Spanish Society of Cardiology to prepare summaries of guidelines established by the ESC
Interview with Ignacio Vega “New developments at iVascular and Cardiva” – CSC 2018
Cardiva’s offices in Portugal, Italy and China boost the company’s growth
6th workshop on "Advanced endovascular management of lower extremity peripheral arterial disease"
“Functional assessment with pressure guides will continue to become more common."
6th Deep Brain Stimulation Course
6th Deep Brain Stimulation Course The Germans Trias i Pujol University Hospital (Barcelona) held the 6th Deep Brain Stimulation Course (first course on Advanced Techniques in Deep Brain Stimulation), chaired by Dr Jordi M. Rimbau, Head of the...
Everything you need to know about aneurysms
Everything you need to know about aneurysms Blood circulates around the human body through different blood vessels. Arteries are one type of blood vessel. They are responsible for transporting oxygenated blood from the heart to...
Interview with Ignacio Vega and Carlos Ibares Sanz
Interview with Ignacio Vega and Carlos Ibares Sanz Ignacio Vega and Carlos Ibares Sanz of Spanish medtech Cardiva, explain the group’s origins as a distributor, the growing importance of manufacturing, and the company’s...
EMBOTRAP recognised as the best medical technology innovation at IMSTA 2018
EMBOTRAP recognised as the best medical technology innovation at IMSTA 2018 IMSTA 2018 recognises EMBOTRAP as the best medical technology innovation in Ireland. The IMSTA MEDTECH AWARDS were held on 27 September in Ireland. These...
